55
Participants
Start Date
October 6, 2014
Primary Completion Date
March 2, 2015
Study Completion Date
March 2, 2015
GSK2140944
GSK2140944 is available in dose strength 1000 mg and 1800 mg for single IV dose over 2 hours administration as a pale yellow to greyish yellow cake for reconstitution
GSK2140944 placebo
GSK2140944 placebo is 0.9% sodium chloride available for single IV dose over 2 hours administration.
Moxifloxacin
Moxifloxacin is available as pinkish red tablet with dose strength 400 mg for single oral dose to be administered in the morning in the fasted state with approximately 240 mL of water.
Moxifloxacin placebo
Moxifloxacin placebo is available as white, film-coated tablet. containing nonactive material for single oral dose to be administered in the morning in the fasted state with approximately 240 mL of water.
GSK Investigational Site, Austin
Lead Sponsor
GlaxoSmithKline
INDUSTRY